Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Beryl Capital Management LLC

Q1 2024 · 13F-HR

Beryl Capital Management LLCholdings as filed

Filed 2024-05-15 · accession 0001214659-24-009291

$82.0M
Reported value
18
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
148806102CTLTEURCATALENT INC$23.8M29.0%420,836CommonSOLE
96684W100WHOLE EARTH BRANDS INC$15.1M18.4%3,118,138CommonSOLE
75629F109RAHSOCIETAL CDMO INC$9.7M11.8%8,942,946CommonSOLE
55616P104MMACYS INC$7.0M8.55%350,908CommonSOLE
14574X104TASTUSDCARROLS RESTAURANT GROUP INC$5.0M6.05%521,566CommonSOLE
L6673X107NGMSUSDNEOGAMES S A$4.3M5.26%149,052CommonSOLE
29978A104EVBGEUREVERBRIDGE INC$3.8M4.59%108,000CommonSOLE
855668109STARRETT L S CO$3.0M3.63%187,555CommonSOLE
25525P107DHCDIVERSIFIED HEALTHCARE TR$2.5M3.01%1,003,785CommonSOLE
23753F107DSKEUSDDASEKE INC$1.8M2.21%218,650CommonSOLE
483548103KAMNUSDKAMAN CORP$1.5M1.79%31,997CommonSOLE
433537107HIRERIGHT HOLDINGS CORPORATI$1.1M1.37%78,698CommonSOLE
G61188101LBTYALIBERTY GLOBAL LTD$1.1M1.36%65,919CommonSOLE
G79407121SCREAMING EAGLE ACQUISITN CO$959,6721.17%2,031,051CommonSOLE
98955G103ZEROFOX HLDGS INC$765,1730.93%683,190CommonSOLE
55345K10337MMRC GLOBAL INC$366,6170.45%29,166CommonSOLE
36118A100FUSION PHARMACEUTICALS INC$345,1920.42%16,191CommonSOLE
12521H115CF ACQUISITION CORP VII$81,9400.10%682,830CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.